SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $85.5K invested in Scinai Immunotherapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26.6K
2
+$22.9K
3
+$4.39K

Top Sellers

1
-$6.56K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$27.5K
Citadel Advisors
2
Citadel Advisors
Florida
$26.6K
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$22.9K
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$7.97K
Morgan Stanley
5
Morgan Stanley
New York
$581